Annual EBITDA
-$81.07 M
+$1.38 B+94.45%
December 31, 2023
Summary
- As of February 8, 2025, PIII annual EBITDA is -$81.07 million, with the most recent change of +$1.38 billion (+94.45%) on December 31, 2023.
- During the last 3 years, PIII annual EBITDA has fallen by -$52.99 million (-188.68%).
- PIII annual EBITDA is now -188.68% below its all-time high of -$28.08 million, reached on December 31, 2020.
Performance
PIII EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$79.14 M
-$78.46 M-11589.07%
September 30, 2024
Summary
- As of February 8, 2025, PIII quarterly EBITDA is -$79.14 million, with the most recent change of -$78.46 million (-11589.07%) on September 30, 2024.
- Over the past year, PIII quarterly EBITDA has dropped by -$78.46 million (-11589.07%).
- PIII quarterly EBITDA is now -11589.07% below its all-time high of -$677.00 thousand, reached on June 30, 2024.
Performance
PIII Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$143.21 M
-$67.98 M-90.36%
September 30, 2024
Summary
- As of February 8, 2025, PIII TTM EBITDA is -$143.21 million, with the most recent change of -$67.98 million (-90.36%) on September 30, 2024.
- Over the past year, PIII TTM EBITDA has dropped by -$67.98 million (-90.36%).
- PIII TTM EBITDA is now -3101.10% below its all-time high of -$4.47 million, reached on June 30, 2020.
Performance
PIII TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PIII EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +94.5% | -10000.0% | -90.4% |
| 3 y3 years | -188.7% | -10000.0% | -90.4% |
| 5 y5 years | -64.2% | -10000.0% | -90.4% |
PIII EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.5% | <-9999.0% | +91.0% | -90.4% | +90.2% |
| 5 y | 5-year | -188.7% | +94.5% | <-9999.0% | +91.0% | -3101.1% | +90.2% |
| alltime | all time | -188.7% | +94.5% | <-9999.0% | +91.0% | -3101.1% | +90.2% |
P3 Health Partners EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$79.14 M(>+9900.0%) | -$143.21 M(+90.4%) |
| Jun 2024 | - | -$677.00 K(-96.9%) | -$75.23 M(-1.4%) |
| Mar 2024 | - | -$21.74 M(-47.8%) | -$76.28 M(-5.9%) |
| Dec 2023 | -$81.07 M(-94.5%) | -$41.66 M(+273.5%) | -$81.07 M(-85.1%) |
| Sep 2023 | - | -$11.15 M(+546.6%) | -$544.89 M(-5.1%) |
| Jun 2023 | - | -$1.73 M(-93.5%) | -$574.29 M(-60.4%) |
| Mar 2023 | - | -$26.53 M(-94.8%) | -$1.45 B(-0.7%) |
| Dec 2022 | -$1.46 B | -$505.48 M(+1146.5%) | -$1.46 B(+52.9%) |
| Sep 2022 | - | -$40.55 M(-95.4%) | -$955.52 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$878.69 M(+2321.8%) | -$944.04 M(+925.9%) |
| Mar 2022 | - | -$36.28 M(+24.8%) | -$92.02 M(+18.1%) |
| Sep 2021 | - | -$29.07 M(+9.0%) | -$77.93 M(+59.5%) |
| Jun 2021 | - | -$26.66 M(+20.1%) | -$48.86 M(+83.2%) |
| Mar 2021 | - | -$22.19 M(+396.1%) | -$26.67 M(+496.1%) |
| Dec 2020 | -$28.08 M(-28.1%) | - | - |
| Jun 2020 | - | -$4.47 M | -$4.47 M |
| Dec 2019 | -$39.04 M(-20.9%) | - | - |
| Dec 2018 | -$49.37 M | - | - |
FAQ
- What is P3 Health Partners annual EBITDA?
- What is the all time high annual EBITDA for P3 Health Partners?
- What is P3 Health Partners annual EBITDA year-on-year change?
- What is P3 Health Partners quarterly EBITDA?
- What is the all time high quarterly EBITDA for P3 Health Partners?
- What is P3 Health Partners quarterly EBITDA year-on-year change?
- What is P3 Health Partners TTM EBITDA?
- What is the all time high TTM EBITDA for P3 Health Partners?
- What is P3 Health Partners TTM EBITDA year-on-year change?
What is P3 Health Partners annual EBITDA?
The current annual EBITDA of PIII is -$81.07 M
What is the all time high annual EBITDA for P3 Health Partners?
P3 Health Partners all-time high annual EBITDA is -$28.08 M
What is P3 Health Partners annual EBITDA year-on-year change?
Over the past year, PIII annual EBITDA has changed by +$1.38 B (+94.45%)
What is P3 Health Partners quarterly EBITDA?
The current quarterly EBITDA of PIII is -$79.14 M
What is the all time high quarterly EBITDA for P3 Health Partners?
P3 Health Partners all-time high quarterly EBITDA is -$677.00 K
What is P3 Health Partners quarterly EBITDA year-on-year change?
Over the past year, PIII quarterly EBITDA has changed by -$78.46 M (-11589.07%)
What is P3 Health Partners TTM EBITDA?
The current TTM EBITDA of PIII is -$143.21 M
What is the all time high TTM EBITDA for P3 Health Partners?
P3 Health Partners all-time high TTM EBITDA is -$4.47 M
What is P3 Health Partners TTM EBITDA year-on-year change?
Over the past year, PIII TTM EBITDA has changed by -$67.98 M (-90.36%)